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1. Introduction 
There is no evidence to support the idea that 
cyclic nucleotides are ‘second messengers’ for steroid 
action. It has been shown, however, that gfucocorti- 
coids, such as cortisol (F) or dexamethasone, in the 
presence of dibutyryl cyclic AMP (DBCAMP) amplifies 
liver tyrosine aminotransferase (TAT) activity to a level 
far greater than that attained by either component 
alone [l-4]. 
Here we show that such interactions occur with 
fragments of normal fetal rat liver in organ culture 
under conditions where neither nucleotide nor steroid 
have any effect alone. Furthermore, we show that 
I I-deoxycortiso1 (S) and I I-deoxycorticosterone 
(DOC), steroids generally considered to be incapable 
of inducing TAT in normal tissue can do so under 
organ culture conditions. 
2. Materials and methods 
2 .I . ~ern~ea~s 
Cortisol, 1 Ia,17,21-trihydroxy-pregn-4ene-3,20- 
dione (1 la-cortisol), 1 I-deoxycorticosterone and 
17,21-dihydroxy-pregn4-ene-3,21-dione (1 l-deoxy- 
cortisol) were bought from Steraloids Corp. (Wilton, 
NH). All steroids were homogeneous when checked 
by thin-layer chromatography. Cyclic nucleotides 
were bought from Calbiochem Corp. (La Jolla, CA). 
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2.2. Animals 
Sprague-Dawley rats were purchased from Camm 
Res. Inst. and maintained at 72°C and 50% humidity. 
Food and water were supplied ad libitum. The light- 
dark cycle was I2 h each. Animals, one of each sex 
per cage, were mated during the 12 h dark period. 
Fetuses were removed under sterile conditions from 
pregnant rats anesthetized with ether. Fetal animals 
at day 20 of gestation were killed by decapitation. 
The livers were immediately placed in ice-cold 0.14 M 
KCl. 
2.3. Organ culture 
The procedures for establishing fetal liver explants 
in organ culture are the same as those we used in [S]. 
When alcohol solutions of steroids were introduced 
into the culture vessels, ethanol was 0.05% final cone. 
Controls with no steroid contained 0.05% ethanol. 
2.4. Em-yme activity 
Liver fragments from one grid were washed in 
0.14 M KC1 and homogenized at O’C in 1 ml 0.9% 
KC1 with an axial homogenizer (Teflon in glass). The 
supernatant fraction obtained after centrifuging at 
18 000 X g for 15 min was used for estimation of 
enzyme activity. Tyrosine aminotransferase was 
measured by the method in [6]. Activity is expressed 
as yg ~-hydroxyphenylpyruvate formed. mg 
protein-’ .20 min-‘. Proteins were measured in the 
liver supernatant fluid by the Lowry method [7]. 
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3. Results 
The ability of several steroids to stnnulate TAT m 
fetal rat liver explants durmg short mcubatlon times 
(I e , for 6 h after estabhshmg explant) IS shown m 
table 1 The results hsted m the ‘no supplement’ 
column confirm that cortlsol does not increase activity 
m this interval 11-deoxycortlsol, DOC, tetrahydro- 
cortlsol (THF) and the 1 lc+eplmer of cortlsol(1 lcu-F) 
were also inactive When DBCAMP was introduced at 
a level which itself produced no Increased TAT, a rise 
m enzyme activity occurred with F, S and DOC 
Neither THF nor the 1 la-F had any effect 
Stlmulatlon of TAT m explants by cortlcosterolds 
requires that the fragments be first subjected to a 
prehmmary mcubatlon period of 24-48 h m the 
absence of steroid [l] Under these condltlons, 
F (2 PM) Increased TAT -3-fold m 6 h (fig 1) To our 
surprise, S at 2 PM also increased TAT about the 
same amount DOC, though less active, was still 
effective THF and 1 la-F dlc’ not stimulate TAT at 
all When the steroids were tested at 2 nM, none was 
effective 
The addltlon of DBCAMP to premcubated cultures 
greatly magnified the effects of the steroids The rela- 
tive increases were the same as m the absence of 
nucleotlde DBCAMP itself mcreased TAT -4-fold 
THF and 1 la-F were again mactlve, And did not 
decrease mductlon by DBCAMP At 20 nM, F was 
still a strong inducer and actlvltles of DOC and S 
were reduced, but measureable 
ImM DBcAMP 
I I 
T 
F S DOC F s DOC THF Ila-F 
Fg 1 Stlmulatlon of tyrosme ammotransferase actlvlty by 
steroids and mixtures of steroids with dlbutyryl cychc AMP 
BdrS mdicate means, limit lines mdlcdte standard devidtlons 
Values beneath bxs show molarlty of steroid m the culture 
dishes DBC AMP wds present dt 1 mM find1 cone Cultures 
were premcubdted for 42 h. then addltlons \~ere made for 
dn additlondl 6 h r, cortlsol. S, 1 ldeoxycortlsol, DOC, 
1 ldeouycortlcosterone, THT, tetrdhydrocortlsol 1 la F. 
1 la-hydroly eplmer of cortl<ol, C. control Actlvlty 1s pg 
p-hydroxyphenyl pyruvlc Jcld formed mg protern-’ 20 mn-’ 
The ablhty of mixtures of DBCAMP and steroid to 
stimulate TAT was probably due to net enzyme 
synthesis Addltlon of cyclohexlmlde to the culture 
medium completely blocked the Inducers 
Although F, S or DOC added to cultures after 42 h 
premcubatlon increased TAT over the followmg 6 h, 
Table 1 
Fffect of stcrolds on the increase m tyrosme ammotransferase activity of fetal 
rat lrver explants with no premcubatlon” 
Stcrold Fnzyme Jet (pgp-hydroxyphenyl pyruvate mg 
protein-’ 20 mm-‘) 
_______ 
No supplement With DBC AMP 
____ -____ 
None 23t09 341;15 
Cortisol 42i22 131+33 
1 ldeo\ycortlsol 12+01 73+11 
1 ldeoxycortlcosterone 18i15 98i29 
tetrahydrocortlsol 28kO4 45+16 
1laCortlsol 20+02 43kO7 
__~~_ ____ 
’ Final concentration of DBC AMP was 1 mM and steroids were 2 phi 
Incubdtlon mterval wds 6 h after addition of the components indicated There was 
no prehmmdry mcubatlon period Values are means and SD for 4-6 experiments 
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Table 2 
Tyrosine aminotransferase activity of fetalrat liver explants incubated continuously 
with steroids for 48 h 
--.___- -- ~_ -~ 
Steroid Enzyme activitya 
- .~_ 
No suppiement with DBC AMP 
--- ~_._.__________ 
none 22.9 f 3.0 80.1 i 20.4 
cortisoi 142.6 ? 56.4 200.0 + 67.9 
1 ldeoxycortisol 30.0 5 5.9 56.8 f 16.8 
1 ldeoxycorticosterone 23.9 i 6.6 75.6 t 26.8 
_ --- 
a Dibutyryl cyclic AMP was 1 mM and steroids were 2 PM 
Values are means and S.D. of 6-10 replicates 
continuous incubation of the steroids with explants one instance prior to our report was there no response 
for the entire 48 h interval led to increased TAT only to either component alone, and an obligatory need 
with F (table 2). The inab~ity of S and DOC to induce for both steroid and nucleotide to initiate new TAT 
TAT persisted even if DBCAMP was present during production [IS]. These results and ours contrast with 
the entire incubation period. For cortisol, the net those in [ 191 where it was found that with hepatoma 
increase in TAT was not greater than the sum of the cells in tissue culture, concentrations of dexamethasone 
irldividual effects of steroid and cyclic nucleotide that do not induce TAT alone fail to support the 
under these conditions. induction by dibutyryl cyclic AMP. 
4. Discussion 
It has long been known that S and DOC are devoid 
of systemic glucocorticoid activity in experimental 
animals and humans [8-l S]. That these steroids could 
stimulate TAT activity in fetal liver is therefore 
unexpected. The concentrations which induced TAT 
in the presence of DBCAMP were 2 X lo-’ M, well 
within the physiological range. In the absence of 
nucleotide, higher levels of steroid were needed to 
induce the enzyme, but the effects were unmistake- 
able. With or without nucleotide, m~imum induc- 
tion with S was as great as with cortisol. Evidently, 
the 1 lfl-hydroxy group, generally accepted as an 
obligatory structural feature of the glucocorticoids, is 
not always required for activity. The effects on nor- 
mal fetal liver of the steroids studied here do not 
parallel those on HTC cells [ 16,171. 
Why cortisol, S and DOC by themselves how a 
significant stimulatory effect on TAT in explants only 
after 42 h preincubation may be related to an increase 
in unoccupied corticosteroid receptors during this 
time [20,21]. In addition, the rate at which the 
freshly isolated explant converts steroids to inactive 
tetrahydro metabol~ies i initially rapid. Endogenous 
and added steroids are rapidly catabolized. Metabo- 
lism is slow after preincubation [22], and as a result, 
the active steroid level is maintained longer. The 
high rate of steroid catabolism of freshly isolated 
liver may also explain the inability of S and DOC 
to induce TAT when incubated with explants for the 
entire 48 h. Extensive metabolism to tetrahydro 
metabolites during the early hours of incubation 
occurs and consequently the final level of active 
unchanged steroid is too low to be effective. 
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